SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031940
Filing Date
2022-11-14
Accepted
2022-11-14 15:23:02
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1779827
2 ex31-1.htm EX-31.1 19126
3 ex31-2.htm EX-31.2 19062
4 ex32-1.htm EX-32.1 8237
5 ex32-2.htm EX-32.2 8280
  Complete submission text file 0001493152-22-031940.txt   9029497

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20220930.xsd EX-101.SCH 52341
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20220930_cal.xml EX-101.CAL 37014
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20220930_def.xml EX-101.DEF 241008
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20220930_lab.xml EX-101.LAB 410942
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20220930_pre.xml EX-101.PRE 310858
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1445201
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 221384335
SIC: 2834 Pharmaceutical Preparations